Abstract
Pharmacometricians are virtually nonexistent in Africa and the developing world. The unrelenting burden of infectious diseases, which are often treated using medicines with narrow effectiveness and safety dose ranges, and the growing prevalence and recognition of non-communicable diseases represent significant threats for the patients, although affording an opportunity for advancing science. This article outlines the case for pharmacometricians to redirect their expertise to focus on the disease burden affecting the developing world. © 2013 ASCPT All rights reserved.
Cite
CITATION STYLE
Pillai, G., Davies, G., Denti, P., Steimer, J. L., McIlleron, H., Zvada, S., … Holford, N. H. G. (2013). Pharmacometrics: Opportunity for reducing disease burden in the developing world: The case of Africa. CPT: Pharmacometrics and Systems Pharmacology, 2(8). https://doi.org/10.1038/psp.2013.45
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.